A woman in Sri Lanka likely developed secondary cold agglutinin disease (CAD) that resulted from a rare type of…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
An autologous stem cell transplant (ASCT) to treat lymphoma, a blood cancer, was safely performed in a man with severe…
Few cases of cold agglutinin disease (CAD) secondary to systemic lupus erythematosus, or SLE, have been reported over the…
A Japanese man with severe anemia — a condition marked by too few red blood cells in the body —…
Warming and an extra dose of corticosteroid medication were part of multiple strategies doctors used to allow for a safe…
Cold agglutinin disease (CAD) was the likely trigger of repeated mini-strokes in an 84-year-old woman with already compromised blood…
Treatment with rituximab — commonly used off-label for cold agglutinin disease (CAD) — was reported to successfully resolve a…
Zydus Lifesciences’ desidustat eases the anemia and red blood cell destruction that mark autoimmune hemolytic anemia, or AIHA, a…
Parsaclisib, an experimental oral therapy from Incyte, safely and effectively increased levels of hemoglobin in about half of people…
Restarting Enjaymo (sutimlimab) after stopping it for up to four months was generally safe and brought blood markers of…